110 related articles for article (PubMed ID: 10805155)
1. Glomerulonephritis with fibrillary deposition in a transgenic mouse carrying the human prototype c-Ha-ras gene (rasH2 mouse).
Kobayashi K; Sano F; Mutai M; Sugimoto J
Toxicol Pathol; 2000; 28(2):359-62. PubMed ID: 10805155
[TBL] [Abstract][Full Text] [Related]
2. Interlaboratory comparison of short-term carcinogenicity studies using CB6F1-rasH2 transgenic mice.
Takaoka M; Sehata S; Maejima T; Imai T; Torii M; Satoh H; Toyosawa K; Tanakamaru ZY; Adachi T; Hisada S; Ueda M; Ogasawara H; Matsumoto M; Kobayashi K; Mutai M; Usui T
Toxicol Pathol; 2003; 31(2):191-9. PubMed ID: 12696579
[TBL] [Abstract][Full Text] [Related]
3. Rapid induction of more malignant tumors by various genotoxic carcinogens in transgenic mice harboring a human prototype c-Ha-ras gene than in control non-transgenic mice.
Yamamoto S; Mitsumori K; Kodama Y; Matsunuma N; Manabe S; Okamiya H; Suzuki H; Fukuda T; Sakamaki Y; Sunaga M; Nomura G; Hioki K; Wakana S; Nomura T; Hayashi Y
Carcinogenesis; 1996 Nov; 17(11):2455-61. PubMed ID: 8968063
[TBL] [Abstract][Full Text] [Related]
4. Hyaline glomerulopathy with tubulo-fibrillary deposits in young ddY mice.
Kouchi M; Toyosawa K; Matsumoto I; Michimae Y; Tochitani T; Koujitani T; Okimoto K; Funabashi H; Seki T
Toxicol Pathol; 2011 Oct; 39(6):975-9. PubMed ID: 21878553
[TBL] [Abstract][Full Text] [Related]
5. Hyaline glomerulopathy in B6C3F1 mice.
Wojcinski ZW; Albassam MA; Smith GS
Toxicol Pathol; 1991; 19(3):224-9. PubMed ID: 1780639
[TBL] [Abstract][Full Text] [Related]
6. Pathological features of spontaneous and induced tumors in transgenic mice carrying a human prototype c-Ha-ras gene used for six-month carcinogenicity studies.
Mitsumori K; Koizumi H; Nomura T; Yamamoto S
Toxicol Pathol; 1998; 26(4):520-31. PubMed ID: 9715511
[TBL] [Abstract][Full Text] [Related]
7. Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing.
Yamamoto S; Urano K; Koizumi H; Wakana S; Hioki K; Mitsumori K; Kurokawa Y; Hayashi Y; Nomura T
Environ Health Perspect; 1998 Feb; 106 Suppl 1(Suppl 1):57-69. PubMed ID: 9539005
[TBL] [Abstract][Full Text] [Related]
8. Twenty-six-week carcinogenicity study of sulfamethoxazole in CB6F1-Tg-rasH2 mice.
Torii M; Itoh F; Yabuuchi K; Ohno K; Kominami G; Hirano K; Tasaki T; Nara H
J Toxicol Sci; 2001 May; 26(2):61-73. PubMed ID: 11429969
[TBL] [Abstract][Full Text] [Related]
9. Skeletal myopathy in transgenic mice carrying human prototype c-Ha-ras gene.
Tsuchiya T; Kobayashi K; Sakairi T; Goto K; Okada M; Sano F; Sugimoto J; Morohashi T; Usui T; Mutai M
Toxicol Pathol; 2002; 30(4):501-6. PubMed ID: 12187941
[TBL] [Abstract][Full Text] [Related]
10. Twenty-six-Week carcinogenicity study of chloroform in CB6F1 rasH2-transgenic mice.
Sehata S; Maejima T; Watanabe M; Ogata S; Makino T; Tanaka K; Manabe S; Takaoka M
Toxicol Pathol; 2002; 30(3):328-38. PubMed ID: 12051550
[TBL] [Abstract][Full Text] [Related]
11. Di(2-ethylhexyl)phthalate induces hepatocellular adenoma in transgenic mice carrying a human prototype c-Ha-ras gene in a 26-week carcinogenicity study.
Toyosawa K; Okimoto K; Kobayashi I; Kijima K; Kikawa E; Kohchi M; Koujitani T; Tanaka K; Matsuoka N
Toxicol Pathol; 2001; 29(4):458-66. PubMed ID: 11560251
[TBL] [Abstract][Full Text] [Related]
12. When noncongophilic glomerular fibrils do not represent fibrillary glomerulonephritis: nonspecific mesangial fibrils in sclerosing glomeruli.
Kronz JD; Neu AM; Nadasdy T
Clin Nephrol; 1998 Oct; 50(4):218-23. PubMed ID: 9799066
[TBL] [Abstract][Full Text] [Related]
13. The Tg rasH2 mouse in cancer hazard identification.
Morton D; Alden CL; Roth AJ; Usui T
Toxicol Pathol; 2002; 30(1):139-46. PubMed ID: 11890467
[TBL] [Abstract][Full Text] [Related]
14. Chemically induced forestomach papillomas in transgenic mice carry mutant human c-Ha-ras transgenes.
Ando K; Saitoh A; Hino O; Takahashi R; Kimura M; Katsuki M
Cancer Res; 1992 Feb; 52(4):978-82. PubMed ID: 1737360
[TBL] [Abstract][Full Text] [Related]
15. The rasH2 transgenic mouse: nature of the model and mechanistic studies on tumorigenesis.
Tamaoki N
Toxicol Pathol; 2001; 29 Suppl():81-9. PubMed ID: 11695564
[TBL] [Abstract][Full Text] [Related]
16. Transgene stability and features of rasH2 mice as an animal model for short-term carcinogenicity testing.
Suemizu H; Muguruma K; Maruyama C; Tomisawa M; Kimura M; Hioki K; Shimozawa N; Ohnishi Y; Tamaoki N; Nomura T
Mol Carcinog; 2002 May; 34(1):1-9. PubMed ID: 12112317
[TBL] [Abstract][Full Text] [Related]
17. Rapid induction of uterine endometrial proliferative lesions in transgenic mice carrying a human prototype c-Ha-ras gene (rasH2 mice) given a single intraperitoneal injection of N-ethyl-N-nitrosourea.
Watanabe T; Kashida Y; Yasuhara K; Koujitani T; Hirose M; Mitsumori K
Cancer Lett; 2002 Dec; 188(1-2):39-46. PubMed ID: 12406546
[TBL] [Abstract][Full Text] [Related]
18. 26-Week carcinogenicity study of di-isodecyl phthalate by dietary administration to CB6F1-rasH2 transgenic mice.
Cho WS; Jeong J; Choi M; Park SN; Han BS; Son WC
Arch Toxicol; 2011 Jan; 85(1):59-66. PubMed ID: 20358181
[TBL] [Abstract][Full Text] [Related]
19. Expression of Ras GTPases in normal kidney and in glomerulonephritis.
Kocher HM; Moorhead J; Sharpe CC; Dockrell ME; Al-Nawab M; Hendry BM
Nephrol Dial Transplant; 2003 Nov; 18(11):2284-92. PubMed ID: 14551355
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by ethinylestradiol of N-ethyl-N-nitrosourea-initiated uterine carcinogenesis in transgenic mice carrying a human prototype C-Ha-ras gene (rasH2 mice).
Watanabe T; Kashida Y; Ueda M; Onodera H; Takizawa T; Hirose M; Mitsumori K
Toxicol Pathol; 2003; 31(5):496-505. PubMed ID: 14692618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
